Memantine neuroprotective agent: Will file an IND and begin a randomized, double-blind, placebo controlled Phase II trial by mid-1996. The oral agent is designe

Neurobiological Technologies Inc. (NTII), Richmond, Calif. Product: Memantine neuroprotective agent Indication: AIDS-related dementia and neuropathic pain Status: Will file an IND and begin a randomi...